MACROH2A2 and ductal breast carcinoma in situ: Similar to the cell lines, mH2A2 was lost in invasive tumors and in tumors with advanced grades (II and III) when compared to ductal carcinoma in situ or grade I tumors, respectively (Fig. 4b).